700844-17-3 Usage
General Description
7-CHLORO-2-IODOTHIENO[3,2-B]PYRIDINE-6-CARBONITRILE is a chemical compound with the molecular formula C7H2ClIN2S. It is a heterocyclic compound containing chlorine, iodine, and nitrile functional groups. 7-CHLORO-2-IODOTHIENO[3,2-B]PYRIDINE-6-CARBONITRILE is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It has potential applications in the development of new drugs and pesticides due to its unique chemical structure. 7-CHLORO-2-IODOTHIENO[3,2-B]PYRIDINE-6-CARBONITRILE may also be used as a building block in organic synthesis for the modification of bioactive compounds and pharmaceutical ingredients. Overall, this chemical compound has diverse potential applications in the fields of medicine, agriculture, and chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 700844-17-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,0,8,4 and 4 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 700844-17:
(8*7)+(7*0)+(6*0)+(5*8)+(4*4)+(3*4)+(2*1)+(1*7)=133
133 % 10 = 3
So 700844-17-3 is a valid CAS Registry Number.
700844-17-3Relevant articles and documents
NEW COMPOUNDS
-
Page/Page column 145; 100, (2012/12/13)
There is provided compounds of formula I, wherein R1, R2a, R2b, R2c, X, Y, Z, R3 and ring A/B have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. PI3-K, particularly class I PI3K, PIM family kinase and/or mTOR) is desired and/or required, and particularly in the treatment of cancer. The invention also relates to combinations containing such compounds.
THIENO[3,2-b]PYRIDINE-6-CARBONITRILES AND THIENO[2,3-b]PYRIDINE-5-CARBONITRILES AS PROTEIN KINASE INHIBITORS
-
Page 80, (2010/02/07)
This invention provides compounds of Formula (1 a) - (1f) wherein:X, R1, and R2 are defined hereinbefore in the specification, which are useful in the treatment of cancer, stroke, osteoporosis, polycystic kidney disease, autoimmune disease, rheumatoid arthritis, and transplant rejection and process for producing said compounds.